Clinical view versus guideline adherence in ferritin monitoring and initiating iron chelation therapy in patients with myelodysplastic syndromes

OBJECTIVES: In patients with myelodysplastic syndromes (MDS) with >20 transfusions and ferritin levels >1000 μg/L, international guidelines recommend iron chelation therapy (ICT). The study's objective was to determine guideline adherence and the intensity of ferritin monitoring in clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Rozema, Johanne, van Asten, Ivar, Kwant, Beau, Kibbelaar, Robby E., Veeger, Nic J. G. M., de Wit, Harry, van Roon, Eric N., Hoogendoorn, Mels
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828450/
https://www.ncbi.nlm.nih.gov/pubmed/36130872
http://dx.doi.org/10.1111/ejh.13865

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828450/
https://www.ncbi.nlm.nih.gov/pubmed/36130872
http://dx.doi.org/10.1111/ejh.13865

Ejemplares similares